Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Discontinue NA Treatment
DRUG
2 trials
Sponsors
University Health Network, Toronto
, Sun Yat-sen University
Conditions
Chronic Hepatitis B
Colorectal Cancer (MSI-H)
Molecular Residual Disease
Phase 4
Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogues
NCT01911156
University Health Network, Toronto
Chronic Hepatitis B
Start: 2013-07-31
End: 2016-03-31
Target: 66
Updated: 2015-05-28
Unknown Phase
Research on Colorectal Cancer Recurrence Monitoring and Individualized Treatment Based on MRD
Recruiting
NCT07775950
Sun Yat-sen University
Colorectal Cancer (MSI-H), Molecular Residual Disease
Start: 2026-06-23
End: 2034-12-30
Target: 100
Updated: 2026-08-20
Related Papers
Early <scp>HBcrAg</scp> and Anti‐<scp>HBc</scp> Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue Cessation—A Pooled Analysis of Two Clinical Trials
Alimentary Pharmacology & Therapeutics
2024-12-03
4 citations
Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study)
Gut
2019-08-28
139 citations